(Q61915218)
Statements
Phase 1 Study of Apatinib as an Inhibitor of Angiogenesis (English)
0 references
July 2007
0 references
June 2008
0 references
18
0 references
18 year
0 references
70 year
0 references
clinical trial
No description defined